{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T03:20:17Z","timestamp":1767842417610,"version":"3.49.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.ajog.2015.01.054","type":"journal-article","created":{"date-parts":[[2015,2,4]],"date-time":"2015-02-04T12:34:27Z","timestamp":1423053267000},"page":"16-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["17-alpha-hydroxyprogesterone caproate for maintenance tocolysis: a systematic review and metaanalysis of randomized trials"],"prefix":"10.1016","volume":"213","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0078-2113","authenticated-orcid":false,"given":"Gabriele","family":"Saccone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anju","family":"Suhag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Berghella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2015.01.054_bib1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0020-7292(03)00247-9","article-title":"Management of preterm labor. ACOG Practice bulletin no. 43","volume":"82","year":"2003","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ajog.2015.01.054_bib2","first-page":"1","article-title":"Births: final data for 2005","volume":"56","author":"Martin","year":"2007","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/j.ajog.2015.01.054_bib3","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1056\/NEJM198501103120204","article-title":"The contribution of low birth weight to infant mortality and childhood morbidity","volume":"312","author":"McCormick","year":"1985","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2015.01.054_bib4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2307\/1602506","article-title":"The direct cost of low birth weight","volume":"5","author":"Lewit","year":"1995","journal-title":"Future Child"},{"key":"10.1016\/j.ajog.2015.01.054_bib5","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0140-6736(05)71048-5","article-title":"Four million neonatal deaths: When? Where? Why?","volume":"365","author":"Lawn","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2015.01.054_bib6","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1056\/NEJMoa067815","article-title":"Progesterone and the risk of preterm birth among women with a short cervix","volume":"357","author":"Fonseca","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2015.01.054_bib7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/uog.9017","article-title":"Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"38","author":"Hassan","year":"2011","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.01.054_bib8","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa035140","article-title":"Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate","volume":"348","author":"Meis","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2015.01.054_bib9","unstructured":"Higgins JPT, Altman DG, Sterne JAC. Chapter 8: Assessing risk of bias in included studies. In:\u00a0Higgins JPT, Green S, eds. Cochrane handbook\u00a0for systematic reviews of interventions, version 5.1.0 (update March 2011). The Cochrane Collaboration, 2011. Available at: www.cochrane-handbook.org. Accessed Aug. 10, 2014."},{"key":"10.1016\/j.ajog.2015.01.054_bib10","unstructured":"PROSPERO: International prospective register of systematic reviews, 2014: CRD42014013473. Available at: www.crd.york.ac.uk\/PROSPERO\/display_record.asp?ID=CRD42014013473. Accessed Aug. 10, 2014."},{"key":"10.1016\/j.ajog.2015.01.054_bib11","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.ajog.2015.01.054_bib12","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1067\/mob.2003.41","article-title":"Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study","volume":"188","author":"da Fonseca","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.01.054_bib13","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1080\/01443610902980878","article-title":"Intravaginal use of natural micronized progesterone to prevent pre-term birth: a randomized trial in India","volume":"29","author":"Majihi","year":"2009","journal-title":"J\u00a0Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2015.01.054_bib14","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/S0140-6736(09)60947-8","article-title":"Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT): a randomized, double-blind, placebo-controlled study and meta-analysis","volume":"373","author":"Norman","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2015.01.054_bib15","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/uog.11174","article-title":"Effect of 17-alpha hydroxyprogesterone caproate on cervical length in twin pregnancies","volume":"40","author":"Lim","year":"2012","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.01.054_bib16","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00404-011-2026-3","article-title":"Single dose 17 alpha hydroxyprogesterone caproate in preterm labor: a randomized trial","volume":"285","author":"Tan","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ajog.2015.01.054_bib17","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ajog.2012.09.013","article-title":"17 Alpha hydroxyprogesterone caproate to prevent prematurity in nulliparas with cervical length less than 30 mm","volume":"207","author":"Grobman","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.01.054_bib18","first-page":"194","article-title":"Prevention of preterm delivery by 17 alpha hydroxyprogesterone caproate in asymptomatic twin pregnancies with a short cervix: a randomized controlled trial","volume":"208","author":"Senat","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.01.054_bib19","first-page":"785","article-title":"Dehghani Firouzabadi R. Efficacy of 17alpha-hydroxyprogesterone on decreasing preterm labor in ART pregnancies: a randomized clinical trial","volume":"11","author":"Aflatoonian","year":"2013","journal-title":"Iran J Reprod Med"},{"key":"10.1016\/j.ajog.2015.01.054_bib20","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/SMJ.0b013e3181afee12","article-title":"Progesterone does not prevent preterm births in women with twins","volume":"102","author":"Briery","year":"2009","journal-title":"South Med J"},{"key":"10.1016\/j.ajog.2015.01.054_bib21","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ijgo.2014.01.019","article-title":"Maintenance tocolysis with oral micronized progesterone for prevention of preterm birth after arrested preterm labor","volume":"126","author":"Choudhary","year":"2014","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ajog.2015.01.054_bib22","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1186\/1756-0500-4-568","article-title":"17-hydroxyprogesterone caproate to prolong pregnancy after preterm rupture of the membranes: early termination of a double-blind, randomized clinical trial","volume":"29","author":"Coombs","year":"2011","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.ajog.2015.01.054_bib23","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1479-828X.2007.00803.x","article-title":"Progesterone for maintenance tocolytic therapy after threatened preterm labor: a randomized controlled trial","volume":"48","author":"Borna","year":"2008","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2015.01.054_bib24","first-page":"45","article-title":"Maintenance therapy by vaginal progesterone after threatened idiopathic preterm labor: a randomized placebo-controlled double blind trial","volume":"4","author":"Sharami","year":"2010","journal-title":"Int J Fertil Steril"},{"key":"10.1016\/j.ajog.2015.01.054_bib25","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000328719","article-title":"Effect of progesterone as a tocolytic and in maintenance therapy during preterm labor","volume":"72","author":"Arikan","year":"2011","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.ajog.2015.01.054_bib26","doi-asserted-by":"crossref","first-page":"678","DOI":"10.3109\/01443615.2013.820266","article-title":"Progesterone use after successful treatment of threatened pre-term delivery","volume":"33","author":"Areia","year":"2013","journal-title":"J\u00a0Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2015.01.054_bib27","doi-asserted-by":"crossref","first-page":"e7947","DOI":"10.5812\/ircmj.7947","article-title":"The effects of progesterone therapy on the gestation length and reduction of neonatal complications in patients who had received tocolytic therapy for acute phase of preterm labor","volume":"15","author":"Lotfalizadeh","year":"2013","journal-title":"Iran Red Crescent Med J"},{"key":"10.1016\/j.ajog.2015.01.054_bib28","doi-asserted-by":"crossref","first-page":"453.e1","DOI":"10.1016\/j.ajog.2006.09.009","article-title":"Cervical length changes during preterm cervical ripening: effects of 17-hydroxyprogesterone caproate","volume":"196","author":"Facchinetti","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.01.054_bib29","doi-asserted-by":"crossref","first-page":"206.e1","DOI":"10.1016\/j.ajog.2011.12.026","article-title":"Prevention of preterm delivery after successful tocolysis in preterm labor by 17 alpha-hydroxyprogesterone caproate: a randomized controlled trial","volume":"206","author":"Rozenberg","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.01.054_bib30","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4172\/2161-0932.1000125","article-title":"Progesterone for prevention of recurrent preterm labor after arrested preterm labor\u2013a randomized controlled trial","volume":"2","author":"Regmi","year":"2012","journal-title":"Gynecol Obstet"},{"key":"10.1016\/j.ajog.2015.01.054_bib31","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.3109\/14767058.2014.892922","article-title":"The use of 17-hydroxy progesterone in women with arrested preterm labor: a randomized clinical trial","volume":"27","author":"Briery","year":"2014","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2015.01.054_bib32","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1097\/AOG.0b013e31825af2f0","article-title":"Management of preterm labor. ACOG Practice bulletin no. 127","volume":"119","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.01.054_bib33","first-page":"CD003927","article-title":"Oral betamimetics for maintenance therapy after threatened preterm labor","volume":"25","author":"Dodd","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2015.01.054_bib34","first-page":"CD003933","article-title":"Terbutaline pump maintenance therapy after threatened preterm labor for preventing preterm birth","volume":"4","author":"Nanda","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2015.01.054_bib35","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S0002-9378(99)70308-X","article-title":"Maintenance oral nifedipine for preterm labor: a randomized clinical trial","volume":"181","author":"Carr","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.01.054_bib36","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1097\/AOG.0b013e31818d8386","article-title":"Maintenance nifedipine tocolysis compared with placebo\u2013a randomized controlled trial","volume":"112","author":"Lyell","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.01.054_bib37","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1515\/JPM.2004.041","article-title":"Oral nifedipine maintenance therapy after acute intravenous tocolysis in preterm labor","volume":"32","author":"Sayin","year":"2004","journal-title":"J\u00a0Perinat Med"},{"key":"10.1016\/j.ajog.2015.01.054_bib38","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0029-7844(95)00016-K","article-title":"Outpatient oral sulindac to prevent recurrence of preterm labor","volume":"85","author":"Carlan","year":"1995","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.01.054_bib39","first-page":"555","article-title":"Sulindac to prevent recurrent preterm labor: a randomized controlled trial","volume":"98","author":"Humprey","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.01.054_bib40","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/0002-9378(93)90055-N","article-title":"Randomized trial of oral indomethacin and terbutaline for the long-term suppression of preterm labor","volume":"169","author":"Bivins","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.01.054_bib41","first-page":"CD000940","article-title":"Magnesium maintenance therapy for preventing preterm birth after threatened preterm labor","volume":"7","author":"Han","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2015.01.054_bib42","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1067\/mob.2000.105816","article-title":"Maintenance treatment of preterm labor with the oxytocin antagonist atosiban","volume":"182","author":"Valenzuela","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.01.054_bib43","first-page":"CD006700","article-title":"Progestational agents for treating threatened or established preterm labor","volume":"1","author":"Su","year":"2014","journal-title":"Cochrane Database Syst Rev"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937815001106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937815001106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:03:43Z","timestamp":1757588623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937815001106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0002937815001106"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2015.01.054","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"17-alpha-hydroxyprogesterone caproate for maintenance tocolysis: a systematic review and metaanalysis of randomized trials","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2015.01.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}